Auteur M. CHANDLER

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Integrating drug-related monitoring systems - An intelligence led approach

M. CHANDLER ; J. McVEIGH ; C. M. BEYNON | 2009
Dans Contemporary Drug Problems (Vol.36, n°3-4, Fall-Winter 2009) Article : Périodique

The Centre for Public Health at Liverpool John Moores University, houses a number of distinct, but related, systems that collate attributable monitoring data from drug treatment, criminal justice, and harm reduction services in the North West of[...]

Plus d'info

Ajouter à la sélection

Meeting the health needs of problematic drug users through community pharmacy: A qualitative study

A. J. MACKRIDGE ; C. M. BEYNON ; J. McVEIGH ; M. WHITFIELD ; M. CHANDLER | 2010
Dans Journal of Substance Use (Vol.15, n°6, December 2010) Article : Périodique

Background: Community pharmacies are established service providers for problematic drug users (PDUs). PDUs have many unmet health needs, which pharmacists may be able to help resolve. This paper aims to qualitatively explore the feasibility and [...]

Plus d'info

Ajouter à la sélection

Lien externe

The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort study in Cheshire and Merseyside, UK

C. M. BEYNON ; J. McVEIGH ; M. CHANDLER ; M. WAREING ; M. A. BELLIS | 2007
Dans Harm Reduction Journal (Vol.4 n°21, 2007) Article : Périodique

ENGLISH : BACKGROUND: In 2003, it became legal in the UK for syringe exchange programmes (SEPs) to provide citrate to injecting drug users to solubilise heroin. Little work has been undertaken on the effect of policy change on SEP function. He[...]

Plus d'info

Ajouter à la sélection